---
title: "Mounjaro (tirzepatide), all indications: Storage and supply questions"
description: "Storage and supply questions on Mounjaro (tirzepatide) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Storage. Questions: How should Mounjaro be stored? How long can Mounjaro be kept out of the refrigerator? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/mounjaro/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Mounjaro (tirzepatide), all indications: Storage and supply questions

Manufacturer: Lilly USA, LLC  
Prescribing information: [Mounjaro](https://uspl.lilly.com/mounjaro/mounjaro.html#pi)  
Indication pages: [Type 2 diabetes](https://www.evicenter.com/medical-information/mounjaro--type-2-diabetes)

## Storage

<a id="mounjaro-storage"></a>

### How should Mounjaro be stored?

> “Do not freeze MOUNJARO. Do not use MOUNJARO if frozen.
> Protect MOUNJARO from heat and light.
> Store MOUNJARO in the original carton to protect from light.
>
> MOUNJARO Single-dose Pen and Single-dose Vial
>
> Store MOUNJARO single-dose pen and single-dose vial in a refrigerator at 2°C to 8°C (36°F to 46°F).
> If needed, each single-dose pen or single-dose vial can be stored unrefrigerated at temperatures not to exceed 30°C (86°F) for up to a total of 21 days.
> Discard the single-dose pen or single-dose vial after a total of 21 days at room temperature.
>
> MOUNJARO Multi-dose Vial or Single-Patient-Use KwikPen
>
> Unopened vial or single-patient-use KwikPen:
>
> Store unopened multi-dose vial or single-patient-use KwikPen in the refrigerator at 2°C to 8°C (36°F to 46°F). The unopened multi-dose vial or single-patient-use KwikPen can be used until the expiration date on the label if kept in the refrigerator.
> If stored at room temperature [up to 30°C (86°F)], throw away unopened multi-dose vial or single-patient-use KwikPen after 30 days.
>
> After vial or single-patient-use KwikPen has been opened:
>
> Store opened (in-use) multi-dose vial or single-patient-use KwikPen in the original carton in the refrigerator at 2°C to 8°C (36°F to 46°F) or at room temperature [up to 30°C (86°F)].
> Throw away opened multi-dose vial or single-patient-use KwikPen after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses, even if there is medicine left in it.”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=Do%20not%20freeze%20MOUNJARO.%20Do,is%20medicine%20left%20in%20it.)

<a id="mounjaro-room-temperature"></a>

### How long can Mounjaro be kept out of the refrigerator?

> “Store each single-dose pen or single-dose vial in the refrigerator between 36⁰F to 46⁰F (2⁰C to 8⁰C). If needed, each single-dose pen or single-dose vial can be stored at room temperature up to 86⁰F (30⁰C) for up to a total of 21 days. Throw away single-dose pen or single-dose vial after a total of 21 days at room temperature.
> Store multi-dose vial or single-patient-use KwikPen in the refrigerator between 36°F to 46°F (2°C to 8°C) or at room temperature [up to 86°F (30°C)]. Throw away the multi-dose vial or single-patient-use KwikPen after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses, even if it still has medicine in it.”

Source: [MOUNJARO: Prescribing information, captured 2026-11-12](https://uspl.lilly.com/mounjaro/mounjaro.html#pi:~:text=Store%20each%20single%2Ddose%20pen%20or,still%20has%20medicine%20in%20it.)

Note: This passage is from the Medication Guide printed with the Prescribing Information.

## Related pages
- [Medical information: Mounjaro (tirzepatide): All indications](https://www.evicenter.com/medical-information/mounjaro)
- [Indication](https://www.evicenter.com/medical-information/mounjaro/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/mounjaro/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/mounjaro/safety)
- [Specific populations](https://www.evicenter.com/medical-information/mounjaro/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/mounjaro/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/mounjaro/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/mounjaro/access-and-coverage)
